Our Pricing

Buy Prescription Weight Loss Treatment UK Online

Published on: June 03, 2026

When you buy prescription weight loss treatment UK online through Cured Pharmacy, you gain access to the latest clinically proven medications from £135.00 all dispensed by our UK-registered clinical team following a free online consultation. Our range includes advanced GLP-1 receptor agonists like Mounjaro, Wegovy, and Saxenda, alongside proven fat-absorption blockers such as Orlistat and Xenical, ensuring you receive the most suitable treatment for your weight management goals.

How Modern Prescription Weight Loss Treatments Work

Prescription weight loss medications approved by the MHRA work through two distinct mechanisms. GLP-1 receptor agonists — including tirzepatide (Mounjaro), semaglutide (Wegovy), and liraglutide (Saxenda) — mimic natural gut hormones that regulate appetite and blood sugar control [1]. These injectable treatments slow gastric emptying and enhance satiety signalling in the brain, helping patients feel fuller for longer periods.

Alternatively, lipase inhibitors like Orlistat and Xenical work locally in the digestive system by blocking approximately 30% of dietary fat absorption [2]. This mechanism suits patients who prefer oral medication and are committed to a reduced-fat diet. Clinical trials demonstrate that when combined with lifestyle modifications, prescription weight loss treatments can support significantly greater weight reduction than diet and exercise alone [3].

Comparing GLP-1 Weight Loss Injections Available in the UK

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK, offering a novel approach by activating two complementary hormone pathways rather than one [1]. In the SURMOUNT-1 trial, participants achieved an average weight reduction of 22.5% over 72 weeks on the highest maintenance dose — substantially higher than single-pathway alternatives [1].

Wegovy delivers semaglutide through a once-weekly injection and demonstrated average weight loss of 14.9% over 68 weeks in the STEP-1 trial [4]. Saxenda uses liraglutide administered daily and showed average reductions of 8% in clinical studies [5]. All three medications require gradual dose escalation over several weeks to minimise gastrointestinal side effects, and your UK prescriber will determine the most appropriate starting dose based on your medical history and weight management objectives.

Which Injectable Treatment Suits Your Needs?

Your clinical assessment will consider factors including your BMI, previous weight loss attempts, medical conditions such as type 2 diabetes, and personal preference regarding injection frequency. Mounjaro's dual-pathway mechanism may benefit patients seeking maximum efficacy, whilst Wegovy offers proven results with once-weekly convenience. Saxenda's daily injection schedule provides more granular dose control but requires consistent daily administration. Subject to prescriber approval, our clinical team will recommend the treatment most aligned with your individual circumstances.

Orlistat-Based Treatments: Oral Weight Loss Options

For patients who prefer oral medication or have contraindications to GLP-1 treatments, Orlistat provides an evidence-based alternative. Available as prescription-strength Xenical (120mg) or lower-strength Alli and Orlos (60mg), Orlistat prevents pancreatic and gastric lipases from breaking down dietary triglycerides [2].

Clinical data shows that Orlistat 120mg combined with a reduced-calorie diet produces approximately 50% greater weight loss than diet modification alone over 12 months [2]. The medication works only when dietary fat is present, making adherence to a lower-fat eating plan essential for optimal results. Gastrointestinal effects such as oily stools and increased bowel movements are common but typically diminish when patients limit fat intake to recommended levels below 30% of total calories.

Choosing Between Prescription and Lower-Strength Orlistat

Xenical's 120mg strength requires a prescription and clinical assessment through Cured Pharmacy, whilst 60mg formulations like Alli and Orlos are available through a pharmacy consultation for adults with BMI 28 or above. The higher prescription dose blocks more dietary fat absorption and typically produces greater weight reduction in clinical trials. Your UK prescriber will assess whether the prescription strength is medically appropriate based on your BMI, existing health conditions, and weight loss targets.

Clinical Evidence Supporting Prescription Weight Loss Treatment

Robust clinical trial data underpins every weight loss medication available through Cured Pharmacy. The SURMOUNT trials for tirzepatide enrolled over 6,500 participants and demonstrated dose-dependent weight reductions ranging from 15% to 22.5% on maintenance doses [1]. The STEP programme evaluated semaglutide across multiple populations including patients with obesity-related comorbidities, consistently showing average reductions exceeding 10% of baseline body weight [4].

NICE guidelines recognise GLP-1 receptor agonists as effective pharmacological interventions for weight management when prescribed alongside comprehensive lifestyle modification programmes [6]. Long-term safety data spanning several years supports the continued use of these medications under medical supervision, though common side effects including nausea, diarrhoea, and constipation affect a significant proportion of patients during dose escalation phases [3][4]. Your UK prescriber will monitor your progress and adjust treatment protocols as needed to optimise both efficacy and tolerability.

How to Buy Prescription Weight Loss Treatment UK Online Safely

Purchasing prescription weight loss medication online in the UK requires clinical oversight from registered healthcare professionals. At Cured Pharmacy (GPhC registration 9012511), every order begins with a comprehensive online consultation reviewed by our UK-registered prescribers. This assessment evaluates your medical history, current medications, contraindications, and suitability for specific weight loss treatments.

Once your prescriber approves treatment, our pharmacy team dispenses genuine UK-licensed medications with complete patient information leaflets and usage instructions. We never supply prescription medicines without valid clinical authorisation, ensuring full compliance with MHRA regulations and GPhC standards. Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical protocols, and our team remains available on (+44) 116 4646009 for any medication queries throughout your treatment journey.

What to Expect During Your Online Consultation

The clinical questionnaire takes under three minutes to complete and covers essential medical information including your weight history, previous weight loss attempts, existing health conditions such as cardiovascular disease or thyroid disorders, and current medications that might interact with weight loss treatments. Our prescribers review each submission individually — this is not an automated approval system. If additional information is needed or if treatment is not clinically appropriate, our team will contact you directly to discuss alternative options or recommend consultation with your NHS GP.

Pricing Transparency and UK Delivery for Weight Loss Medications

Cured Pharmacy displays all treatment costs upfront before you begin your consultation, eliminating surprise fees or hidden charges. Our weight loss range starts from £135.00 for Saxenda, with competitive UK pricing across all GLP-1 injectable treatments and Orlistat formulations. Every price includes your clinical consultation, prescriber review, medication supply, and discreet home delivery with tracking.

We guarantee the lowest prices in the UK market and dispatch all orders in unmarked packaging to protect your privacy. Standard delivery reaches most UK addresses within 2-3 working days, with next-day options available for urgent requirements. All medications are sourced directly from licensed UK wholesalers and stored in our temperature-controlled pharmacy facility, ensuring you receive genuine products with full remaining shelf life. If your prescribed treatment is temporarily unavailable due to national supply constraints, our clinical team will contact you to discuss suitable alternatives at comparable pricing.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
3. Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015). Pharmacological management of obesity: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 100(2), 342–362. https://doi.org/10.1210/jc.2014-3415 [accessed 13 August 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., Wilding, J. P., & NN8022-1807 Study Group. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
6. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (Clinical guideline CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.